Literature DB >> 34935525

Omicron: A Speculation on Its Potential Superpowers.

Rodney S Russell1.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34935525     DOI： 10.1089/vim.2021.0213

Source DB:  PubMed          Journal:  Viral Immunol        ISSN： 0882-8245            Impact factor:   2.257


× No keyword cloud information.
  4 in total

1.  Longitudinal Randomized Cohort Study of SARS-CoV-2 Antibody Seroprevalence in the St. Petersburg Population.

Authors:  Vyacheslav S Smirnov; Liudmila V Lyalina; Anzhelika M Milichkina; Irina V Khamitova; Elena V Zueva; Valery A Ivanov; Vitaly S Zaguzov; Areg A Totolian
Journal:  Viruses       Date:  2022-04-27       Impact factor: 5.818

2.  Molecular SARS-CoV-2 surveillance in Bavaria shows no Omicron transmission before the end of November 2021.

Authors:  Jennifer Flechsler; Ute Eberle; Alexandra Dangel; Nikolaus Ackermann; Andreas Sing; Sabrina Hepner; Clara Wimmer; Johannes Lutmayr; Regina Konrad; Carola Berger; Laura Weise; Annika Sprenger; Jörg Zeitler; Natali Paravinja; Hildegard Angermeier; George Githure; Sandra Schmidt; Bianca Treis; Mercy Okeyo; Bernhard Liebl
Journal:  Infection       Date:  2022-03-01       Impact factor: 7.455

3.  The SARS-CoV-2 Omicron (B.1.1.529) variant and effectiveness of existing vaccines: What we know so far.

Authors:  Md Sohan; Md Jamal Hossain; Md Rabiul Islam
Journal:  J Med Virol       Date:  2022-01-13       Impact factor: 20.693

4.  Role of Omicron variant of SARS-CoV-2 in children in Germany.

Authors:  Stefan Bittmann
Journal:  World J Pediatr       Date:  2022-02-01       Impact factor: 9.186
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.